NSE · JUBLINGREA · Chemicals
Jubilant Ingrevia Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹1,253 Cr with net profit ₹126 Cr — a 10.08% net margin, versus 9.62% the period before.
Shareholding
As of 2026-06-30
- Promoter45.22%
- Public23.3%
- FII6.49%
- DII24.98%
1,10,949 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.57× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Chemicals · ranked #21 of 159 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Pidilite Industries Ltd. | ₹1,65,890 Cr | 67.35 | 15.31 | 22.61% | 16.77% |
| Solar Industries India Ltd. | ₹1,63,362 Cr | 93.51 | 26.02 | 26.72% | 17.05% |
| SRF Ltd. | ₹77,213 Cr | 34.46 | 5.5 | 13.07% | 13.01% |
| Linde India Limited | ₹56,603 Cr | 103.24 | 13.27 | 12.87% | 21.69% |
| Gujarat Fluorochemicals Ltd. | ₹48,279 Cr | 443.04 | 6.19 | 7.3% | 11.49% |
| Godrej Industries Ltd. | ₹44,101 Cr | 99.27 | 3.95 | 11.1% | 5.58% |
| Himadri Speciality Chem Limited | ₹38,370 Cr | 191.08 | 8.15 | 15.96% | 16.12% |
| Navin Fluorine International Ltd. | ₹37,898 Cr | 58.47 | 9.53 | 16.69% | 20.02% |
| Deepak Nitrite Ltd. | ₹22,422 Cr | 102.04 | 3.84 | 9.43% | 6.98% |
| Atul Ltd. | ₹20,029 Cr | 95.31 | 3.22 | 9.31% | 8.93% |
| Jubilant Ingrevia Limited(this company) | ₹11,603 Cr | 133.17 | 3.67 | 8.89% | 6.4% |
AI analysis
AI-generated · google/gemini-2.5-flashJubilant Ingrevia Limited is listed with a market capitalization of Rs 11737 Cr. The company reported revenue of Rs 4215.43 Cr and a profit margin of 6.4%. Its P/E ratio is 134.71, and it has an EPS of Rs 18.06. The 52-week high for the share price was Rs 845.55, and the 52-week low was Rs 537.3.
Positives
- +Revenue grew 1% to Rs 4215.43 Cr annually.
- +The debt-to-equity ratio is 0.27, indicating low leverage.
- +The company maintains a dividend yield of 34%.
Negatives
- −Promoter shareholding decreased from 50.68% in March 2021 to 45.22% in June 2026.
- −9.3% of promoter shares are pledged as of June 30, 2026.
- −The profit margin is 6.4%, which is relatively thin.
- −The P/E ratio is 134.71, which is high.
Financial Performance
Jubilant Ingrevia Limited reported revenue of Rs 4215.43 Cr in the fiscal year ending March 2025, with a revenue growth rate of 1%. The company's net profit for the same period was Rs 251.182 Cr. Quarterly revenue for March 2026 was Rs 1178.65 Cr with a net profit of Rs 86.44 Cr. For the quarter ending December 2025, revenue was Rs 1050.91 Cr with a net profit of Rs 46.9 Cr.
Profitability & Returns
The company's profit margin stands at 6.4%. Return on equity (ROE) is 8.89%, and return on capital employed (ROCE) is 10.37%. The earnings per share (EPS) for the latest reported annual period is Rs 18.06. The company also offers a dividend yield of 34%.
Balance Sheet
Jubilant Ingrevia Limited maintains a debt-to-equity ratio of 0.27, indicating a relatively low reliance on debt financing. The book value per share is Rs 196.28.
Ownership & Pledges
As of June 30, 2026, promoter holding in Jubilant Ingrevia Limited was 45.22%. Foreign Institutional Investors (FIIs) held 6.49%, while Domestic Institutional Investors (DIIs) held 24.98%. Public shareholding was 23.30%. A total of 9.3% of promoter shares are pledged. The promoter shareholding has decreased from 50.68% in March 2021 to 45.22% in June 2026.
Data as of — price: 2026-07-30 · financials: Jun 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.